Gene · 1870
Papers2,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell total-RNA profiling unveils regulatory hubs of transcription factors. | Nat Commun | 2024 | 39009595 | PubTator, text mining | PubMed |
| The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma. | Cancer Immunol Immunother | 2024 | 38954021 | PubTator, text mining | PubMed |
| UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL. | Clin Mol Hepatol | 2024 | 38915206 | PubTator, text mining | PubMed |
| A novel signature based on twelve programmed cell death patterns to predict the prognosis of lung adenocarcinoma. | Am J Transl Res | 2024 | 38883377 | PubTator, text mining | PubMed |
| Molecular insights into regulatory RNAs in the cellular machinery. | Exp Mol Med | 2024 | 38871819 | PubTator, text mining | PubMed |
| ZFHX3 acts as a tumor suppressor in prostate cancer by targeting FTO-mediated m6A demethylation. | Cell Death Discov | 2024 | 38871709 | PubTator, text mining | PubMed |
| Spatiotemporal expression and control of haemoglobin in space. | Nat Commun | 2024 | 38862545 | PubTator, text mining | PubMed |
| The role of E2F2 in cancer progression and its value as a therapeutic target. | Front Immunol | 2024 | 38807594 | PubTator, text mining | PubMed |
| A cell cycle regulator, E2F2, and glucocorticoid receptor cooperatively transactivate the bovine alphaherpesvirus 1 immediate early transcription unit 1 promoter. | J Virol | 2024 | 38771044 | PubTator, text mining | PubMed |
| Primitive new termites (Blattodea, Termitoidae) in Cretaceous amber from Myanmar. | Zookeys | 2024 | 38651112 | PubTator, text mining | PubMed |
| Characterization of a G2M checkpoint-related gene model and subtypes associated with immunotherapy response for clear cell renal cell carcinoma. | Heliyon | 2024 | 38617927 | PubTator, text mining | PubMed |
| ZMIZ1 enhances ERα-dependent expression of E2F2 in breast cancer. | J Mol Endocrinol | 2024 | 38564418 | PubTator, text mining | PubMed |
| Exosomal circSTRBP from cancer cells facilitates gastric cancer progression via regulating miR-1294/miR-593-3p/E2F2 axis. | J Cell Mol Med | 2024 | 38520208 | PubTator, text mining | PubMed |
| Large-scale phosphoproteomics reveals activation of the MAPK/GADD45β/P38 axis and cell cycle inhibition in response to BMP9 and BMP10 stimulation in endothelial cells. | Cell Commun Signal | 2024 | 38439036 | PubTator, text mining | PubMed |
| Aqueous Extract of Leaves and Flowers of Acmella caulirhiza Reduces the Proliferation of Cancer Cells by Underexpressing Some Genes and Activating Caspase-3. | Biochem Res Int | 2024 | 38371392 | PubTator, text mining | PubMed |
| The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal squamous cell carcinoma pathomorphological features. | BMC Cancer | 2024 | 38360622 | PubTator, text mining | PubMed |
| Comprehensive review regarding the association of E2Fs with the prognosis and immune infiltrates in human head and neck squamous cell carcinoma. | Asian J Surg | 2024 | 38320907 | PubTator, text mining | PubMed |
| Circ_0000877 accelerates proliferation and immune escape of non-small cell lung cancer cells by regulating microRNA-637/E2F2 axis. | Environ Toxicol | 2024 | 38317501 | PubTator, text mining | PubMed |
| Macrophage heterogeneity and its interactions with stromal cells in tumour microenvironment. | Cell Biosci | 2024 | 38303024 | PubTator, text mining | PubMed |
| Malignant peritoneal mesotheliomas of rats induced by multiwalled carbon nanotubes and amosite asbestos: transcriptome and epigenetic profiles. | Part Fibre Toxicol | 2024 | 38297314 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1870/papers?page=6